TrialImmunity, inflammation and disease2018

A clinical follow-up of omalizumab in routine treatment of allergic asthma monitored by CD-sens.

S Gunnar O Johansson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.